XLerateHealth Selects 6 Healthcare Startups for 2021 Flint Accelerator Cohort

FLINT, Mich.--()--XLerateHealth (XLH), a nationally recognized healthcare accelerator headquartered in Louisville KY, today announced the selection of six startup companies to participate in its 2021 Flint cohort. This year’s program will be fully virtual following on last year’s success in light of COVID adaptations. XLH Flint is funded by the Charles Stewart Mott Foundation and 100K Ideas.

“We have seen exciting traction for XLH Flint companies over the last two years in regards to partnerships, funding and customer discovery,” said Jackie Willmot, CEO and co-founder of XLH. “We are excited to welcome a great class this year and are grateful for the continued support and engagement of the local Flint community.”

Over the last year, XLH Flint alumni companies have seen success including:

  • HealthOpX is working with Genesee County Free Medical Clinic, Latinos United for Flint and University of Michigan Flint to submit a grant application to improve healthcare access and utilization. The organization is also in pilot phases with CareFirst BlueCross BlueShield.
  • Crosby Innovations entered into a patent and technology license partnership with Orlando-based Healthe Inc., which will manufacture a UVC 222nm cleaning device that cleanses hands or gloves of viruses and bacteria.

The Flint cohort kicks off its accelerator program on July 15, and will culminate with a virtual Demo Day pitch to investors, healthcare ecosystem partners, and the startup community on Sept. 22nd.

XLerateHealth’s 2021 Flint Cohort

Adlore™ (Kalamazoo, MI) is designing a next generation device for the treatment of lower extremity wounds, including diabetic/neuropathic foot ulcers, venous stasis leg wounds, arterial and ischemic ulcers. The device incorporates proprietary SenLore™ technology to improve healing rates by supplying heat, thermo-regulated electrical pulse stimulation to increase blood flow, and a feedback sensor to monitor performance.

DRS.LINQ (Newton, PA) is creating a virtual cardiology office to enable enhanced connectivity between the patient and physician through proprietary vEKG and the mHeart App and Cloud. The mHeart platform leverages remote monitoring technology to help break the cycle of clinicians sending patients with chest pain to the Emergency Room.

Intuitool Devices, Inc. (St Louis, MO) is a medical device company that utilizes elegant ergonomic designs to create innovative and cost-effective laparoscopic tools. These instruments provide adaptive surgical solutions to reduce surgeon discomfort from repetitive motion injury and enhance intra-operative functionality.

Isaab Innovations (Flint, MI) is a physician-founded medical device company that has innovated a patent protected syringe to improve medication delivery. MultiFlow syringe incorporates the flushing solution in one syringe to reduce catheter access, thereby reducing bloodstream infections, improving patient outcomes and reducing associated healthcare costs.

MyHelse™ (North Beach, MD) is a customizable Platform as a Service that leverages data and analytics to identify early risks at both the individual and population health level. Focused on underserved populations, including American Indian, MyHelse aims to improve care delivery and health outcomes through data-informed early intervention, lifestyle changes, care coordination, and financial planning.

Vern Health (East Lansing, MI) detects emotions in communication in real time to support telehealth, customer service, and more. Vern Health utilizes proprietary AI diagnostic technology that integrates with any software stack with API, MLOps, and SDK deployments available.

About XLerateHealth

The XLerateHealth (XLH) mission is to cultivate and grow impactful healthcare innovation in the Midwest, Southeast and other areas of the country where great innovation often goes unrecognized and underfunded. Founded in 2012, XLH supports the development of healthcare innovation through its healthcare accelerator, which helps start-up founders commercialize their business and attract funding. XLerateHealth also leads the efforts to build and operate the XLerator Network, an NIH-funded partnership with Academic Lead University of Kentucky along with 24 other academic institutions in the Southeast. The objective of this work is to increase the commercialization of promising life science and healthcare innovations in the NIH-designated Southeast Institutional Development Award (IDeA) states.

Find out more about XLH by visiting www.xleratehealth.com. XLH is on Facebook, LinkedIn and Twitter @XlerateHealth.


Kallie Knop, kallie@letsthinkstrategy.com 704 617 0582


Kallie Knop, kallie@letsthinkstrategy.com 704 617 0582